195 related articles for article (PubMed ID: 25591676)
1. Clinical heterogeneity and a high proportion of novel mutations in a Chinese cohort of patients with dysferlinopathy.
Xi J; Blandin G; Lu J; Luo S; Zhu W; Béroud C; Pécheux C; Labelle V; Lévy N; Urtizberea JA; Zhao C; Krahn M
Neurol India; 2014; 62(6):635-9. PubMed ID: 25591676
[TBL] [Abstract][Full Text] [Related]
2. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
[TBL] [Abstract][Full Text] [Related]
3. The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants.
Wang N; Han X; Hao S; Han J; Zhou X; Sun S; Tang J; Lu Y; Wu H; Ma S; Song X; Ji G
BMC Neurol; 2022 Nov; 22(1):398. PubMed ID: 36319958
[TBL] [Abstract][Full Text] [Related]
4. Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.
Cacciottolo M; Numitone G; Aurino S; Caserta IR; Fanin M; Politano L; Minetti C; Ricci E; Piluso G; Angelini C; Nigro V
Eur J Hum Genet; 2011 Sep; 19(9):974-80. PubMed ID: 21522182
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
[TBL] [Abstract][Full Text] [Related]
6. Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy.
Kawabe K; Goto K; Nishino I; Angelini C; Hayashi YK
Eur J Neurol; 2004 Oct; 11(10):657-61. PubMed ID: 15469449
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous characteristics of Korean patients with dysferlinopathy.
Park HJ; Hong JM; Suh GI; Shin HY; Kim SM; Sunwoo IN; Suh BC; Choi YC
J Korean Med Sci; 2012 Apr; 27(4):423-9. PubMed ID: 22468107
[TBL] [Abstract][Full Text] [Related]
8. Dysferlinopathies: Clinical and genetic variability.
Ivanova A; Smirnikhina S; Lavrov A
Clin Genet; 2022 Dec; 102(6):465-473. PubMed ID: 36029111
[TBL] [Abstract][Full Text] [Related]
9. Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.
Azakir BA; Di Fulvio S; Kinter J; Sinnreich M
J Biol Chem; 2012 Mar; 287(13):10344-10354. PubMed ID: 22318734
[TBL] [Abstract][Full Text] [Related]
10. Null variants in DYSF result in earlier symptom onset.
Park HJ; Hong YB; Hong JM; Yun U; Kim SW; Shin HY; Kim SM; Choi YC
Clin Genet; 2021 Mar; 99(3):396-406. PubMed ID: 33215690
[TBL] [Abstract][Full Text] [Related]
11. Rapid screening for Japanese dysferlinopathy by fluorescent primer extension.
Hayashi S; Ohsawa Y; Takahashi T; Suzuki N; Okada T; Rikimaru M; Murakami T; Aoki M; Sunada Y
Intern Med; 2010; 49(24):2693-6. PubMed ID: 21173544
[TBL] [Abstract][Full Text] [Related]
12. Two common mutations (p.Gln832X and c.663+1G>C) account for about a third of the DYSF mutations in Korean patients with dysferlinopathy.
Park YE; Kim HS; Lee CH; Nam TS; Choi YC; Kim DS
Neuromuscul Disord; 2012 Jun; 22(6):505-10. PubMed ID: 22297152
[TBL] [Abstract][Full Text] [Related]
13. New aspects on patients affected by dysferlin deficient muscular dystrophy.
Klinge L; Aboumousa A; Eagle M; Hudson J; Sarkozy A; Vita G; Charlton R; Roberts M; Straub V; Barresi R; Lochmüller H; Bushby K
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):946-53. PubMed ID: 19528035
[TBL] [Abstract][Full Text] [Related]
14. Dysferlinopathy in Tunisia: clinical spectrum, genetic background and prognostic profile.
Belhassen I; Laroussi S; Sakka S; Rekik S; Lahkim L; Dammak M; Authier FJ; Mhiri C
Neuromuscul Disord; 2023 Oct; 33(10):718-727. PubMed ID: 37716854
[TBL] [Abstract][Full Text] [Related]
15. Lipid accumulation in dysferlin-deficient muscles.
Grounds MD; Terrill JR; Radley-Crabb HG; Robertson T; Papadimitriou J; Spuler S; Shavlakadze T
Am J Pathol; 2014 Jun; 184(6):1668-76. PubMed ID: 24685690
[TBL] [Abstract][Full Text] [Related]
16. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.
Nguyen K; Bassez G; Bernard R; Krahn M; Labelle V; Figarella-Branger D; Pouget J; Hammouda el H; Béroud C; Urtizberea A; Eymard B; Leturcq F; Lévy N
Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010686
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.
Takahashi T; Aoki M; Suzuki N; Tateyama M; Yaginuma C; Sato H; Hayasaka M; Sugawara H; Ito M; Abe-Kondo E; Shimakura N; Ibi T; Kuru S; Wakayama T; Sobue G; Fujii N; Saito T; Matsumura T; Funakawa I; Mukai E; Kawanami T; Morita M; Yamazaki M; Hasegawa T; Shimizu J; Tsuji S; Kuzuhara S; Tanaka H; Yoshioka M; Konno H; Onodera H; Itoyama Y
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):433-40. PubMed ID: 23243261
[TBL] [Abstract][Full Text] [Related]
18. Dysferlin mutation in a Chinese pedigree with Miyoshi myopathy.
Shunchang S; Fan Q; Huacheng W; Leturcq F; Yongjian S; Bingfeng Z; Wen Y; Deburgrave N
Clin Neurol Neurosurg; 2006 Jun; 108(4):369-73. PubMed ID: 16023782
[TBL] [Abstract][Full Text] [Related]
19. Exome sequencing as a second-tier diagnostic approach for clinically suspected dysferlinopathy patients.
Bartoli M; Desvignes JP; Nicolas L; Martin K
Muscle Nerve; 2014 Dec; 50(6):1007-10. PubMed ID: 25046369
[TBL] [Abstract][Full Text] [Related]
20. Dysferlinopathy in Iran: Clinical and genetic report.
Fatehi F; Nafissi S; Urtizberea JA; Blanck-Labelle V; Lévy N; Krahn M; Dbouk MB; Attarian S
J Neurol Sci; 2015 Dec; 359(1-2):256-9. PubMed ID: 26671124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
